Clinical trials recruiting for Abemaciclib
3
Recruiting trials
0
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 3 1Not applicable 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Abemaciclib | 1 |
| Endocrine Therapy (ET): letrozole, anastrozole, exemestane, tamoxifen | 1 |
| Endocrine therapy + Abemaciclib | 1 |
| Palbociclib | 1 |
| Ribociclib | 1 |
Self-screener
Recruiting trials
- Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)
- Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea
- Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
Related conditions
Trials recruiting for Abemaciclib often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Hormone Receptor Positive Breast Cancer 24Breast Neoplasms 105Microbiome 12HR-positive, HER2-negative Advanced Breast Cancer 5HR+/HER2- Breast Cancer 17Hormone Receptor Positive HER-2 Negative Breast Cancer 8Hormone Receptor Positive Breast Carcinoma 13Endocrine Therapy 4CDK4/6 Inhibitor 4
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Abemaciclib trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.